Next generation sequencing diagnostics of relapsing/refractory acquired pure red cell aplasia in adults (PRCA-NGS2017 study)

Next generation sequencing diagnostics of relapsing/refractory acquired pure red cell aplasia in adults (PRCA-NGS2017 study) - NGS diagnostics in PRCA

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000033866

Enrollment

100

Registered

2018-09-01

Start date

2018-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acquired pure red cell aplasia (PRCA)

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Acquired pure red cell aplasia in adults

Exclusion criteria

Exclusion criteria: None

Countries

Japan

Contacts

Public ContactMakoto Hirokawa

Akita University Department of General Internal Medicine and Clinical Laboratory Medicine, Graduate School of Medicin

mhirokawa@hos.akita-u.ac.jp018-884-6209

Outcome results